World Financial News Network Favors Regal One (RONE) Helping People with Stem Cell Research

Share Article

Summary: Dr. Joseph de Beauchamp of World Financial News Network gives favorable analysis Regal One (RONE) helping people with stem cell research.

WFNN's consistently outperforms established industry benchmark indicators. Based on in-depth research and analysis, their analysts recommend securities worldwide showing the highest probability for stock price appreciation. With constant vigil, WFNN looks for economic opportunities in the private and public company sectors.

Dr. Joseph de Beauchamp, WFNN's Chief Independent Analyst, said, “Changing to a development company; this helps RONE or Regal One launch to the next level. Several mergers look to happen very soon. With Stem cell research moving fast, we see this stock moving up to the $5.00 range within a few short months.”

For information of this dynamic company examine: and displaying in the search engine section.

About WFNN: World Financial News Network provides a unique blend of data, timely information and today's technologies to assist with up-to-the-minute investment and economic values on markets and investments around the world.

About Regal One: Regal One (RONE) provides research and products in the area of stem cell. Under the development company, WFNN sees this company picking up some companies to help in the area of stem cell research. They currently look to be involved with air cleaning devices to help with homeland security also.

Dr. Joseph de Beauchamp, Pubic relations


# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joseph De Beauchamp
Email >